Vertex Pharmaceuticals · 1 day ago
Associate Director, Computational Genomics
Vertex Pharmaceuticals is a global biotechnology company that invests in scientific innovation. They are seeking an experienced computational biologist to lead the Boston-based computational genomics team, focusing on leveraging genomic data to advance drug discovery and development programs.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
As the Computational Genomics team lead for Boston Research, you will work with your team members and disease project teams to identify and prioritize key project questions, design genomic studies, and interpret results to drive project progress
As a part of the global leadership for the Computational Genomics team, work across sites to prioritize global needs to maximize impact across the global research portfolio
Oversee computational genomic activities of your team, including providing scientific guidance, resource management, and leadership to ensure impactful and timely completion of studies, with adherence to data integrity and documentation policies
Ensure continuous talent development to attract, retain, and develop your team members
Partner across the rest of the Data & Computational Sciences department to prioritize, develop, and evolve computational methods and best practice guidelines for key analyses
Establish and maintain productive relationships with key stakeholders such as the Boston Research leadership across the organization
Qualification
Required
Advanced understanding in the fields of genomics, human genetics, statistics and/or computational biology, such as bulk and single cell transcriptomics, pooled variant screening, genome-wide association studies
A proven track record in the analysis, visualization, and interpretation of large-scale genomic data in a drug development context
Excellent scientific critical thinking, with the ability to understand the value, risks, and challenges of various approaches, synthesize and interpret complex data, and propose recommendations to drive forward progress
Demonstrated ability to work across cross-functional teams, ensuring proactive collaboration and timely progress
Superior communication skills demonstrating confidence and versatility in presenting verbally to diverse audiences and writing technical documents, including experience presenting to senior and executive leadership
A team-oriented growth mindset that welcomes feedback from others and supports other team members; a positive attitude that enthusiastically tackles and overcomes challenges
Highly skilled in mentoring others, resolving technical problems, maintaining procedural and ethical standards, and cultivating healthy team morale
PhD degree (or Master's degree) in computational biology, bioinformatics, human genetics, genomics, systems biology, bioengineering, or a related field with 5+ years (or 8+ years for Master's degree) of productive, relevant industry experience and 2 years of management experience, or the equivalent combination of education and experience
Demonstrated leadership abilities, such as management of a high-performing team, leadership of a scientific project, mentorship of junior scientists
Benefits
Medical, dental and vision benefits
Generous paid time off (including a week-long company shutdown in the Summer and the Winter)
Educational assistance programs including student loan repayment
A generous commuting subsidy
Matching charitable donations
401(k)
Company
Vertex Pharmaceuticals
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.
H1B Sponsorship
Vertex Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (188)
2024 (150)
2023 (111)
2022 (164)
2021 (112)
2020 (80)
Funding
Current Stage
Public CompanyTotal Funding
$657.31MKey Investors
Janssen Belgium
2024-07-10Post Ipo Secondary· $1.11M
2022-05-17Post Ipo Equity· $50M
2009-12-03Post Ipo Equity· $443M
Leadership Team
Recent News
2026-01-05
2026-01-05
Company data provided by crunchbase